Atomwise Raises $123 Million to Accelerate AI Drug Discovery
Drug discovery startup recently raised $123 million bringing the total amount of capital the company has raised to date to almost $175 million. Atomwise plans to use the new financing to continue to scale its AI technology platform, grow its internal pipeline of small molecule drug programs, and continue portfolio development of joint venture companies….
